TuHURA Biosciences (HURA) Total Current Liabilities (2012 - 2026)

TuHURA Biosciences' Total Current Liabilities history runs 15 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 26.86% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 26.86% YoY), while the FY2025 annual figure was $5.9 million, up 11.06% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $6.1 million, up from $5.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $15.2 million in Q2 2025, with the low at $1.3 million in Q1 2024.
• The 5-year median for Total Current Liabilities is $3.5 million (2022), against an average of $4.6 million.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities tumbled 51.94% in 2024, then soared 571.61% in 2025.
• TuHURA Biosciences' Total Current Liabilities stood at $3.2 million in 2022, then increased by 11.03% to $3.6 million in 2023, then jumped by 48.2% to $5.3 million in 2024, then grew by 11.06% to $5.9 million in 2025, then advanced by 2.49% to $6.1 million in 2026.
• Business Quant data shows HURA's Total Current Liabilities at $6.1 million in Q1 2026, $5.9 million in Q4 2025, and $8.8 million in Q3 2025.